Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers

NCT03205358 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningitis
Meningococcal Meningitis
Meningococcal Infections

Interventions

BIOLOGICAL: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
BIOLOGICAL: Meningococcal Polysaccharide groups A, C, W-135 and Y Conjugate Vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company